139 related articles for article (PubMed ID: 34822863)
1. Rotenone impairs learning and memory in mice through microglia-mediated blood brain barrier disruption and neuronal apoptosis.
Guo Z; Ruan Z; Zhang D; Liu X; Hou L; Wang Q
Chemosphere; 2022 Mar; 291(Pt 2):132982. PubMed ID: 34822863
[TBL] [Abstract][Full Text] [Related]
2. Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson's Disease Mouse Model.
Ruan Z; Zhang D; Huang R; Sun W; Hou L; Zhao J; Wang Q
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269933
[TBL] [Abstract][Full Text] [Related]
3. Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson's disease model.
Zhang D; Li S; Hou L; Jing L; Ruan Z; Peng B; Zhang X; Hong JS; Zhao J; Wang Q
J Neuroinflammation; 2021 Jan; 18(1):4. PubMed ID: 33402167
[TBL] [Abstract][Full Text] [Related]
4. Microglial gp91phox-mediated neuroinflammation and ferroptosis contributes to learning and memory deficits in rotenone-treated mice.
Tian L; Tang P; Liu J; Liu Y; Hou L; Zhao J; Wang Q
Free Radic Biol Med; 2024 Aug; 220():56-66. PubMed ID: 38697489
[TBL] [Abstract][Full Text] [Related]
5. Microglial Activation Mediates Noradrenergic Locus Coeruleus Neurodegeneration via Complement Receptor 3 in a Rotenone-Induced Parkinson's Disease Mouse Model.
Jing L; Hou L; Zhang D; Li S; Ruan Z; Zhang X; Hong JS; Wang Q
J Inflamm Res; 2021; 14():1341-1356. PubMed ID: 33859489
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of microglia dampens blood-brain barrier permeability and loss of dopaminergic neurons in paraquat-lesioned mice.
Zhou YT; Xu YN; Ren XY; Zhang XF
Food Chem Toxicol; 2023 Apr; 174():113692. PubMed ID: 36842752
[TBL] [Abstract][Full Text] [Related]
7. Complement receptor 3-mediated neurotoxic glial activation contributes to rotenone-induced cognitive decline in mice.
Wang Q; Ruan Z; Jing L; Guo Z; Zhang X; Liu J; Tian L; Sun W; Song S; Hong JS; Shih YI; Hou L; Wang Q
Ecotoxicol Environ Saf; 2023 Nov; 266():115550. PubMed ID: 37832486
[TBL] [Abstract][Full Text] [Related]
8. A novel synthetic peptide SVHRSP attenuates dopaminergic neurodegeneration by inhibiting NADPH oxidase-mediated neuroinflammation in experimental models of Parkinson's disease.
Zhang X; Tu D; Li S; Li N; Li D; Gao Y; Tian L; Liu J; Zhang X; Hong JS; Hou L; Zhao J; Wang Q
Free Radic Biol Med; 2022 Aug; 188():363-374. PubMed ID: 35760232
[TBL] [Abstract][Full Text] [Related]
9. Ultrafine carbon particles promote rotenone-induced dopamine neuronal loss through activating microglial NADPH oxidase.
Wang Y; Liu D; Zhang H; Wang Y; Wei L; Liu Y; Liao J; Gao HM; Zhou H
Toxicol Appl Pharmacol; 2017 May; 322():51-59. PubMed ID: 28283350
[TBL] [Abstract][Full Text] [Related]
10. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons.
Gao HM; Liu B; Hong JS
J Neurosci; 2003 Jul; 23(15):6181-7. PubMed ID: 12867501
[TBL] [Abstract][Full Text] [Related]
11. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons.
Mount MP; Lira A; Grimes D; Smith PD; Faucher S; Slack R; Anisman H; Hayley S; Park DS
J Neurosci; 2007 Mar; 27(12):3328-37. PubMed ID: 17376993
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal Activated Microglia May Contribute to Blood-Brain Barrier Impairment and Cognitive Dysfunction in Post-Traumatic Stress Disorder-Like Rats.
Ni K; Zhu J; Xu X; Liu Y; Yang S; Huang Y; Xu R; Jiang L; Zhang J; Zhang W; Ma Z
J Mol Neurosci; 2022 May; 72(5):975-982. PubMed ID: 35167061
[TBL] [Abstract][Full Text] [Related]
14. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine inhibits transient global ischemia-induced hippocampal neuronal death and memory impairment by preventing blood-brain barrier disruption.
Lee JY; Lee HE; Kang SR; Choi HY; Ryu JH; Yune TY
Neuropharmacology; 2014 Apr; 79():161-71. PubMed ID: 24316161
[TBL] [Abstract][Full Text] [Related]
16. Minocycline diminishes the rotenone induced neurotoxicity and glial activation via suppression of apoptosis, nitrite levels and oxidative stress.
Verma DK; Singh DK; Gupta S; Gupta P; Singh A; Biswas J; Singh S
Neurotoxicology; 2018 Mar; 65():9-21. PubMed ID: 29360531
[TBL] [Abstract][Full Text] [Related]
17. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.
Gao HM; Hong JS; Zhang W; Liu B
J Neurosci; 2002 Feb; 22(3):782-90. PubMed ID: 11826108
[TBL] [Abstract][Full Text] [Related]
18. Mild hypoxia triggers transient blood-brain barrier disruption: a fundamental protective role for microglia.
Halder SK; Milner R
Acta Neuropathol Commun; 2020 Oct; 8(1):175. PubMed ID: 33115539
[TBL] [Abstract][Full Text] [Related]
19. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus.
Pérez-Hernández M; Fernández-Valle ME; Rubio-Araiz A; Vidal R; Gutiérrez-López MD; O'Shea E; Colado MI
Neuropharmacology; 2017 May; 118():157-166. PubMed ID: 28322979
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase-1 regulates microglia mediated decrease of endothelial tight junction integrity.
Mehrabadi AR; Korolainen MA; Odero G; Miller DW; Kauppinen TM
Neurochem Int; 2017 Sep; 108():266-271. PubMed ID: 28461173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
